Today: 17 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Rigetti (RGTI) stock jumps as quantum names rebound; SEC filing flags insider sale plan

Rigetti (RGTI) stock jumps as quantum names rebound; SEC filing flags insider sale plan

Rigetti shares jumped 6.6% to $23.60 Friday, trading over 37 million shares as tech stocks rebounded to start 2026. Director Alissa Fitzgerald filed to sell 59,316 shares, valued at about $1.31 million, after the close. The stock traded between $21.62 and $24.00. Investors are watching for U.S. jobs data Jan. 9 and Rigetti’s earnings in early March.
3 January 2026
··
Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Pfizer shares closed up 1.1% at $25.18 on Friday, after leading U.S. drugmakers in January list-price hikes, including a 15% increase for its COVID vaccine Comirnaty. The stock remains below its 52-week high of $27.69. Investors await Pfizer’s Feb. 3 earnings update and monitor upcoming U.S. jobs and inflation data.
3 January 2026
····
Starbucks stock today: SBUX slips after MrBeast tie-up as investors eye earnings and rates

Starbucks stock today: SBUX slips after MrBeast tie-up as investors eye earnings and rates

Starbucks shares closed down 0.3% at $83.97 Friday, about 29% below their 52-week high. The company announced a marketing tie-in with YouTube creator MrBeast’s “Beast Games” and a limited-time drink launching Jan. 14. Investors are watching upcoming earnings, U.S. store changes, and the timeline for Starbucks’ China joint venture with Boyu Capital.
3 January 2026
··
MercadoLibre stock (MELI) drops 2% as 2026 opens; traders eye $2,000 and next catalysts

MercadoLibre stock (MELI) drops 2% as 2026 opens; traders eye $2,000 and next catalysts

MercadoLibre shares fell 2.0% to $1,973.70 Friday, closing below both their 50-day and 200-day moving averages after Zacks Research downgraded the stock to “strong sell.” The stock now trades about 25% below its 52-week high, with a market cap near $100 billion. U.S. markets are closed Saturday. Investors await the company’s next earnings report, expected around Feb. 19.
3 January 2026
·
KLA stock surges nearly 5% to start 2026 as chip-gear rally puts KLAC near a new high

KLA stock surges nearly 5% to start 2026 as chip-gear rally puts KLAC near a new high

KLA shares closed up 4.89% at $1,274.47 Friday, near their 52-week high, as semiconductor equipment stocks rallied on the first trading day of 2026. The Philadelphia Semiconductor Index rose 4%, with Lam Research and Applied Materials also posting strong gains. ASML’s U.S. shares jumped 8.8% after an analyst upgrade. Investors now await U.S. jobs data and KLA’s upcoming earnings report.
3 January 2026
·
Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week

Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week

Merck shares rose 1.2% to $106.45 Friday after Nasdaq set Jan. 6 as the expiration for its $9.2 billion cash tender offer for Cidara Therapeutics. Cidara shares will be halted after Jan. 6 and suspended Jan. 8 if the merger closes as planned. Merck’s move snapped a three-day losing streak, leaving the stock just below its 52-week high. About 10 million shares traded, below the 50-day average.
3 January 2026
···
Chevron stock (CVX) in spotlight after Trump vows billions for Venezuela oil reset

Chevron stock (CVX) in spotlight after Trump vows billions for Venezuela oil reset

President Donald Trump said U.S. oil firms are ready to invest in Venezuela after Nicolás Maduro’s capture by U.S. forces, but the U.S. oil embargo remains. Chevron shares rose 2.3% Friday, closing at $155.90, as energy stocks outperformed despite Brent crude trading near $61 a barrel. PDVSA’s operations continued without disruption, sources said. OPEC+ meets Sunday to discuss output policy amid oversupply concerns.
3 January 2026
···
1 … 440 441 442 443 444 … 741

Stock Market Today

  • Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models
    April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast, a discounted cash flow (DCF) model values shares at $47.64, signaling overvaluation based on cash flow projections. This valuation split highlights uncertain assumptions about Symbotic's ability to translate its backlog into sustainable cash earnings, with risks including customer concentration and contract delays.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:51 AM EDT India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks April 17, 2026, 4:51 AM EDT. **Foreign institutional investors (FIIs)** are growing cautious on India as new **foreign exchange (FX) restrictions** by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive.
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop